Skip to main content
Earnings Labs
AC

Actuate Therapeutics Inc (ACTU)

NASDAQ·Healthcare·Biotechnology

$1.07

-3.60%

Mkt Cap $30.15M

Analyst Ratings

Buy

3

Hold

0

Sell

0

Price Target (1 analysts)

$21.00

Range $21.00$21.00

Implied Upside

+1862.6%

Consensus $21.00 vs current $1.07